184 related articles for article (PubMed ID: 24602846)
1. Expression of GRP78 predicts taxane-based therapeutic resistance and recurrence of human gastric cancer.
Yang L; Yang S; Liu J; Wang X; Ji J; Cao Y; Lu K; Wang J; Gao Y
Exp Mol Pathol; 2014 Apr; 96(2):235-41. PubMed ID: 24602846
[TBL] [Abstract][Full Text] [Related]
2. [GRP78 expression in gastric cancer and its clinical significance].
Yang L; Yang SY; Ji JM; Cao YF; Ji CF; Ji JF; Xu WW; Wang JH
Zhonghua Zhong Liu Za Zhi; 2013 Nov; 35(11):837-42. PubMed ID: 24447482
[TBL] [Abstract][Full Text] [Related]
3. Low expression of DLC1 is predictive of poor therapeutic efficiency of fluoropyrimidine and oxaliplatin as adjuvant chemotherapy in gastric cancer.
Su Y; Lin L; Zhang J; Jiang Y; Pan C; Sun L; Duan J; Liao W
Mol Med Rep; 2015 Oct; 12(4):5771-9. PubMed ID: 26239822
[TBL] [Abstract][Full Text] [Related]
4. Glucose-regulated protein GRP78 is up-regulated in prostate cancer and correlates with recurrence and survival.
Daneshmand S; Quek ML; Lin E; Lee C; Cote RJ; Hawes D; Cai J; Groshen S; Lieskovsky G; Skinner DG; Lee AS; Pinski J
Hum Pathol; 2007 Oct; 38(10):1547-52. PubMed ID: 17640713
[TBL] [Abstract][Full Text] [Related]
5. Prognostic role of BiP/GRP78 expression as ER stress in patients with gastric adenocarcinoma.
Ogawa H; Kaira K; Takahashi K; Shimizu A; Altan B; Yoshinari D; Asao T; Oyama T
Cancer Biomark; 2017 Sep; 20(3):273-281. PubMed ID: 28854502
[TBL] [Abstract][Full Text] [Related]
6. GRP78 as a novel predictor of responsiveness to chemotherapy in breast cancer.
Lee E; Nichols P; Spicer D; Groshen S; Yu MC; Lee AS
Cancer Res; 2006 Aug; 66(16):7849-53. PubMed ID: 16912156
[TBL] [Abstract][Full Text] [Related]
7. GRP78 as potential predictor for breast cancer response to adjuvant taxane therapy.
Lee E; Nichols P; Groshen S; Spicer D; Lee AS
Int J Cancer; 2011 Feb; 128(3):726-31. PubMed ID: 20473863
[TBL] [Abstract][Full Text] [Related]
8. Overexpression of GRP78 and GRP94 are markers for aggressive behavior and poor prognosis in gastric carcinomas.
Zheng HC; Takahashi H; Li XH; Hara T; Masuda S; Guan YF; Takano Y
Hum Pathol; 2008 Jul; 39(7):1042-9. PubMed ID: 18482745
[TBL] [Abstract][Full Text] [Related]
9. Predictive value of microtubule-associated protein Tau in patients with recurrent and metastatic breast cancer treated with taxane-containing palliative chemotherapy.
Zhou J; Qian S; Li H; He W; Tan X; Zhang Q; Han G; Chen G; Luo R
Tumour Biol; 2015 May; 36(5):3941-7. PubMed ID: 25773385
[TBL] [Abstract][Full Text] [Related]
10. miR-135a promotes gastric cancer progression and resistance to oxaliplatin.
Yan LH; Chen ZN; Li-Li ; Chen J; Wei WE; Mo XW; Qin YZ; Lin Y; Chen JS
Oncotarget; 2016 Oct; 7(43):70699-70714. PubMed ID: 27683111
[TBL] [Abstract][Full Text] [Related]
11. CXCR6 predicts poor prognosis in gastric cancer and promotes tumor metastasis through epithelial-mesenchymal transition.
Jin JJ; Dai FX; Long ZW; Cai H; Liu XW; Zhou Y; Hong Q; Dong QZ; Wang YN; Huang H
Oncol Rep; 2017 Jun; 37(6):3279-3286. PubMed ID: 28440473
[TBL] [Abstract][Full Text] [Related]
12. Association of elevated GRP78 expression with increased lymph node metastasis and poor prognosis in patients with gastric cancer.
Zhang J; Jiang Y; Jia Z; Li Q; Gong W; Wang L; Wei D; Yao J; Fang S; Xie K
Clin Exp Metastasis; 2006; 23(7-8):401-10. PubMed ID: 17187227
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of TMPRSS4 in gastric cancer.
Sheng H; Shen W; Zeng J; Xi L; Deng L
Neoplasma; 2014; 61(2):213-7. PubMed ID: 24299317
[TBL] [Abstract][Full Text] [Related]
14. miR-126: An indicator of poor prognosis and recurrence in histologically lymph node-negative gastric cancer.
Feng R; Sah BK; Li J; Lu S; Yuan F; Jin X; Yan M; Liu B; Li C; Zhu Z
Cancer Biomark; 2018; 23(3):437-445. PubMed ID: 30248047
[TBL] [Abstract][Full Text] [Related]
15. Evaluation of Slug expression is useful for predicting lymph node metastasis and survival in patients with gastric cancer.
Lee HH; Lee SH; Song KY; Na SJ; O JH; Park JM; Jung ES; Choi MG; Park CH
BMC Cancer; 2017 Oct; 17(1):670. PubMed ID: 28974196
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of PAK4 expression in gastric cancer.
Kobayashi K; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Sato Y; Yanaka Y; Higuchi K; Aburatani T; Tomii C; Uetake H; Kojima K; Kawano T
J Clin Pathol; 2016 Jul; 69(7):580-5. PubMed ID: 26614788
[TBL] [Abstract][Full Text] [Related]
17. Relationship between expression of IGFBP7 and clinicopathological variables in gastric cancer.
Sato Y; Inokuchi M; Takagi Y; Otsuki S; Fujimori Y; Yanaka Y; Kobayashi K; Higuchi K; Kojima K; Kawano T
J Clin Pathol; 2015 Oct; 68(10):795-801. PubMed ID: 26043748
[TBL] [Abstract][Full Text] [Related]
18. The benefit of microsatellite instability is attenuated by chemotherapy in stage II and stage III gastric cancer: Results from a large cohort with subgroup analyses.
Kim SY; Choi YY; An JY; Shin HB; Jo A; Choi H; Seo SH; Bang HJ; Cheong JH; Hyung WJ; Noh SH
Int J Cancer; 2015 Aug; 137(4):819-25. PubMed ID: 25614197
[TBL] [Abstract][Full Text] [Related]
19. Expression of glucose regulated protein 78 (GRP78) determines colorectal cancer response to chemotherapy.
Mhaidat NM; Alzoubi KH; Almomani N; Khabour OF
Cancer Biomark; 2015; 15(2):197-203. PubMed ID: 25519021
[TBL] [Abstract][Full Text] [Related]
20. RAD51B as a potential biomarker for early detection and poor prognostic evaluation contributes to tumorigenesis of gastric cancer.
Cheng Y; Yang B; Xi Y; Chen X
Tumour Biol; 2016 Nov; 37(11):14969-14978. PubMed ID: 27651161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
